[vc_row][vc_column][vc_column_text][metaslider id=232]

 

Cyberknife treatment options

Stereotactic radiosurgery technology Cyberknife is a device for non-invasive treatment that lets successfully cure not only both malignant and benign tumours, but also some other types of diseases including various vascular anomalies, epilepsy and Parkinson’s disease. The therapy doesn’t require surgical intervention and the patient won’t feel any discomfort or pain during the procedure, furthermore, after Cyberknife radiosurgery there is no need to stay in the clinic and the patient can go home already the same day. Cyberknife treatment, combined with the work of professionals, provides impeccable precision that allows to preserve the healthy tissue and adjust the therapy to tumours that cannot be treated surgically.

Cyberknife radiosurgery for prostate cancer and other cancer types can be applied both as the primary treatment method and the combination therapy together with surgery, radiation or chemotherapy. Cyberknife treatment is particularly useful in situations when the tumour or its metastasis are located in areas that are hard to reach, such as the head or spinal cord, as well as in the moving organs, for example the prostate or the lungs. In such cases standard surgery is often not possible, while Cyberknife radiosurgery for prostate cancer and other cancer types allows to eradicate pathological formations without threatening the patient’s life functions. Cyberknife radiosurgery for prostate cancer and other cancer types is also suited for cases where a tumour or benign formation is located close to a vital organ or centre as well as situations when the patient for some reason doesn’t want to undergo a surgical manipulation.

One of the most essential Cyberknife benefit is its ability to precisely locate the cancerous organ and to actively adjust the device’s position synchronously to the moving organ. The tumour can be irradiated with the precision of a tenth of a millimeter, thus acting precisely on the cancerous tissue and minimizing damage to the healthy tissue. This is particularly essential when treating tumours that constantly change their location, such as carcinoma in the lungs or liver that moves with each patient’s inhalation and exhalation.

In order to be able to treat a tumour with Cyberknife, it must meet certain criteria. The tumour must not be too large – the treatable size depends on the organ where it is located. In addition, the formation must have a clearly identifiable shape. The method most effectively eradicates formations with the radius of no more than five centimeters and metastases no larger than four centimeters. For certain types of oncological diseases, such as lung cancer, the technology can be used only during the first and second stages. The earlier the stage of a tumour, the more extensive therapy options are available and the better the expected effect. Cyberknife treatment is not recommended for patients with a predicted life expectancy of less than six months and for children under the age of 12 years.

It is important to note that each case is examined individually. The suitability of Cyberknife cancer treatment for a particular patient is always determined by appropriate medical examinations. Before the procedure, each patient receives an individual treatment procedure to make sure it’s as safe and precise as possible.

 

Are you diagnosed with cancer?

 

What types of oncological diseases can be treated with Cyberknife?

 

Cyberknife treatment for brain cancer, benign, malicious tumours and metastases in the brain

• Tumours located in various areas of the brain and brain metastases of cancer localized in another body part. Symptoms of such a tumour include regular headache, impaired sight, speech, hearing, or balance.
• Acoustic neuroma or vestibular schwannoma. Benign, most commonly an encapsulated neuromuscular tumour, which can cause noises in the ears, impaired hearing and balance, and headache. Progression of the tumour causes additional pressure to some parts of the brain resulting in pain, numbness and other health problems.
• Meningioma. In most cases, a benign tumour in the brain cortex, the progression of which causes compression resulting in headache, dizziness and other unpleasant symptoms.
• Angioma. Benign vascular tumour that consists of blood vessels and lymph nodes.
• Pituitary adenoma. Most commonly a benign tumour that is formed from the tissue of the internal secretion gland pituitary. The tumour growth can seriously impair the visual function, hormonal balance, cause formation of cysts and other diseases.

 

Cyberknife treatment for tumours and metastases in the lungs

• Cancer of the respiratory organs – the lungs and bronchus – and some metastases from malignant tumours of other organs. Lung cancer symptoms include severe cough, often with bloody sputum, increased body temperature and chest pain. Cyberknife technology allows treating lung cancer at stages one and two.

 

Cyberknife treatment for tumours and metastases in the liver

• Primary hepatic carcinoma and metastases of malignant tumours of other organs. Liver cancer is indicated by appetite disorders and jaundice that affects the skin, the eyes and the mucous membranes. One of the most important risk factors for liver cancer is various liver diseases, such as hepatitis, cirrhosis and fatty liver disease.

 

Cyberknife treatment for tumours in the pancreas

• Pancreatic carcinoma. This tumour is indicated by such symptoms as jaundice, chronic abdominal pain, appetite disorders, skin diseases and diabetes.

 

Cyberknife treatment for tumours and metastases in the spinal cord

• Spinal tumour and spinal vertebra metastases from a tumour localised in another body part.
• Spinal meningioma. In most cases, a benign tumour of the spinal meninges, the progression of which results in compression that causes motor and sensory disturbances and back pain.
• Spinal neurinoma. A benign nerve tissue tumour of the spinal canal, which causes severe pain in the back area. Growth of the tumour can cause damage of the spinal cord.

 

Cyberknife treatment for prostate cancer and metastases in the prostate

• Primary and metastatic tumour of the prostate gland. Symptoms of such a carcinoma includes impotence, urination difficulty, blood in the urine, and lower abdominal pain.

 

Cyberknife treatment for tumours and metastases in the bones

• Malignant tumour inside the bones – the chest, spine, skull and metastases from a tumour localized in another body part. Bone cancer is indicated by pain, inflammation, brittle bones, anemia and sleep disorders.

 

Cyberknife treatment for tumours and metastases in the kidneys

• Kidney carcinoma and kidney metastases from a tumour localized in another body part. Disease symptoms include pain in the kidney area, increased body temperature and blood in the urine.
• Urethral tumour. Symptoms include urination disruptions, blood in the urine, and pain in the right and left side of the abdomen, pelvis or lower back.

 

Cyberknife treatment for solitary metastases from the breast tumour

• Metastasis of mammary gland carcinoma can be in various locations – in the brain, lung, liver and other parts of the body. The symptoms depends on location of metastasis.

 

Cyberknife treatment for tumours in the area of the head and neck

• Malignant and benign formations in the nasopharynx, throat, tongue.
• Neck lymph node metastases of a tumour localized in another body part.

 

Cyberknife treatment for tumours in the eye

• Uveal melanoma. Symptoms include visual impairment – blurriness, partial or complete loss of vision, spots drifting in the field of vision.

 

What types of non-oncological diseases can be treated with Cyberknife?

 

Various vascular changes and pathologies

• Arteriovenous malformation. Pathological connection between the brain’s arteries and veins that allows the blood to rapidly flow into the venous system bypassing the surrounding tissue. With Cyberknife technology, it is possible to treat vascular pathologies less than three centimeters in size, deeply localized and compact.
• Trigeminal neuralgia. Pressure to the trigeminal nerve caused by a vascular pathology or tumour that causes severe pain in the area of the face, usually one side of the face. The patient experiences impaired mimicry movement including food intake or speech.

 

To get more information about how Cyberknife surgery for prostate cancer and other cancer types can help you, please use this form to send in your results and you’ll get an answer from us as soon as possible.
[/vc_column_text][/vc_column][/vc_row]